List of Excipients in API FLUTICASONE FUROATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing FLUTICASONE FUROATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Haleon US Holdings LLC | FLONASE SENSIMIST | fluticasone furoate | 0135-0615 | ANHYDROUS DEXTROSE | 2028-07-15 |
| Haleon US Holdings LLC | FLONASE SENSIMIST | fluticasone furoate | 0135-0615 | BENZALKONIUM CHLORIDE | 2028-07-15 |
| Haleon US Holdings LLC | FLONASE SENSIMIST | fluticasone furoate | 0135-0615 | CARBOXYMETHYLCELLULOSE SODIUM | 2028-07-15 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for FLUTICASONE FUROATE
Excipient focus: ANHYDROUS DEXTROSE
FLUTICASONE FUROATE drug variants containing ANHYDROUS DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | fluticasone furoate | 0135-0615 |
| Haleon US Holdings LLC | fluticasone furoate | 0135-0616 |
| A-S Medication Solutions | fluticasone furoate | 50090-5967 |
| >Company | >Ingredient | >NDC |
FLUTICASONE FUROATE drug variants not containing ANHYDROUS DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | fluticasone furoate | 0173-0888 |
| Prasco Laboratories | fluticasone furoate | 66993-166 |
| Prasco Laboratories | fluticasone furoate and vilanterol | 66993-135 |
| >Company | >Ingredient | >NDC |
Excipient focus: BENZALKONIUM CHLORIDE
FLUTICASONE FUROATE drug variants containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | fluticasone furoate | 0135-0615 |
| Haleon US Holdings LLC | fluticasone furoate | 0135-0616 |
| A-S Medication Solutions | fluticasone furoate | 50090-5967 |
| >Company | >Ingredient | >NDC |
FLUTICASONE FUROATE drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | fluticasone furoate | 0173-0888 |
| Prasco Laboratories | fluticasone furoate | 66993-166 |
| Prasco Laboratories | fluticasone furoate and vilanterol | 66993-135 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
FLUTICASONE FUROATE drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | fluticasone furoate | 0135-0615 |
| Haleon US Holdings LLC | fluticasone furoate | 0135-0616 |
| A-S Medication Solutions | fluticasone furoate | 50090-5967 |
| >Company | >Ingredient | >NDC |
FLUTICASONE FUROATE drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | fluticasone furoate | 0173-0888 |
| Prasco Laboratories | fluticasone furoate | 66993-166 |
| Prasco Laboratories | fluticasone furoate and vilanterol | 66993-135 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
FLUTICASONE FUROATE drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | fluticasone furoate | 0135-0615 |
| Haleon US Holdings LLC | fluticasone furoate | 0135-0616 |
| A-S Medication Solutions | fluticasone furoate | 50090-5967 |
| >Company | >Ingredient | >NDC |
FLUTICASONE FUROATE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | fluticasone furoate | 0173-0888 |
| Prasco Laboratories | fluticasone furoate | 66993-166 |
| Prasco Laboratories | fluticasone furoate and vilanterol | 66993-135 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
FLUTICASONE FUROATE drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | fluticasone furoate | 0135-0615 |
| Haleon US Holdings LLC | fluticasone furoate | 0135-0616 |
| A-S Medication Solutions | fluticasone furoate | 50090-5967 |
| >Company | >Ingredient | >NDC |
FLUTICASONE FUROATE drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | fluticasone furoate | 0173-0888 |
| Prasco Laboratories | fluticasone furoate | 66993-166 |
| Prasco Laboratories | fluticasone furoate and vilanterol | 66993-135 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
FLUTICASONE FUROATE drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | fluticasone furoate | 0173-0888 |
| Prasco Laboratories | fluticasone furoate | 66993-166 |
| Prasco Laboratories | fluticasone furoate and vilanterol | 66993-135 |
| >Company | >Ingredient | >NDC |
FLUTICASONE FUROATE drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | fluticasone furoate | 0135-0615 |
| Haleon US Holdings LLC | fluticasone furoate | 0135-0616 |
| A-S Medication Solutions | fluticasone furoate | 50090-5967 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
FLUTICASONE FUROATE drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Prasco Laboratories | fluticasone furoate and vilanterol | 66993-135 |
| GlaxoSmithKline LLC | fluticasone furoate and vilanterol trifenatate | 0173-0859 |
| GlaxoSmithKline LLC | fluticasone furoate and vilanterol trifenatate | 0173-0916 |
| >Company | >Ingredient | >NDC |
FLUTICASONE FUROATE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | fluticasone furoate | 0135-0615 |
| Haleon US Holdings LLC | fluticasone furoate | 0135-0616 |
| GlaxoSmithKline LLC | fluticasone furoate | 0173-0888 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
FLUTICASONE FUROATE drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | fluticasone furoate | 0135-0615 |
| Haleon US Holdings LLC | fluticasone furoate | 0135-0616 |
| A-S Medication Solutions | fluticasone furoate | 50090-5967 |
| >Company | >Ingredient | >NDC |
FLUTICASONE FUROATE drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | fluticasone furoate | 0173-0888 |
| Prasco Laboratories | fluticasone furoate | 66993-166 |
| Prasco Laboratories | fluticasone furoate and vilanterol | 66993-135 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
FLUTICASONE FUROATE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | fluticasone furoate | 0135-0615 |
| Haleon US Holdings LLC | fluticasone furoate | 0135-0616 |
| A-S Medication Solutions | fluticasone furoate | 50090-5967 |
| >Company | >Ingredient | >NDC |
FLUTICASONE FUROATE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | fluticasone furoate | 0173-0888 |
| Prasco Laboratories | fluticasone furoate | 66993-166 |
| Prasco Laboratories | fluticasone furoate and vilanterol | 66993-135 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
